Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Hicks

Showing results (241-250 of 263) with videos related to

Pageof 27
Sort By:
Pediatric Nephrology (Berlin, Germany)|March 29, 2022
Utility of the 2018 revised ISN/RPS thresholds for glomerular crescents in childhood-onset lupus nephritis: a Pediatric Nephrology Research Consortium studyPooja Patel, Marietta de Guzman, M John Hicks, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 8, 2021
CHAF1A Blocks Neuronal Differentiation and Promotes Neuroblastoma Oncogenesis via Metabolic ReprogrammingLing Tao, Myrthala Moreno-Smith, Rodrigo Ibarra-García-Padilla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2015
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive SarcomaNabil Ahmed, Vita S Brawley, Meenakshi Hegde, et al.
The Journal of Experimental Medicine|March 19, 2014
BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groupsMarie-Luise Berres, Karen Phaik Har Lim, Tricia Peters, et al.
Nature Communications|November 18, 2015
Recurrent internal tandem duplications of BCOR in clear cell sarcoma of the kidneyAngshumoy Roy, Vijetha Kumar, Barry Zorman, et al.
Nature Communications|July 17, 2020
Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcomaMeenakshi Hegde, Sujith K Joseph, Farzana Pashankar, et al.
Pediatric Blood & Cancer|December 26, 2025
Factors Associated With Rare Pediatric Cancer Trial Enrollment: A Report From the Children's Oncology Group Rare Tumors CommitteeBrian R Englum, Jin Piao, Lindsay Younis, et al.
Cancer Research|November 30, 2017
TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast CancerTiara T Byrd, Kristen Fousek, Antonella Pignata, et al.
Haematologica|June 7, 2021
Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndromeAyala Tovy, Carina Rosas, Amos S Gaikwad, et al.
Pediatric Blood & Cancer|May 9, 2025
Pediatric Malignant Tumors in Malawi: A Diagnostic Report From the Kamuzu Central Hospital Pathology Laboratory 2011-2020Yolanda Gondwe, April Evans, Apatsa Matatiyo, et al.
Pageof 27

Showing results (241-250 of 263) with videos related to

Sort By:
Pageof 27
Pediatric Nephrology (Berlin, Germany)|March 29, 2022
Utility of the 2018 revised ISN/RPS thresholds for glomerular crescents in childhood-onset lupus nephritis: a Pediatric Nephrology Research Consortium studyPooja Patel, Marietta de Guzman, M John Hicks, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 8, 2021
CHAF1A Blocks Neuronal Differentiation and Promotes Neuroblastoma Oncogenesis via Metabolic ReprogrammingLing Tao, Myrthala Moreno-Smith, Rodrigo Ibarra-García-Padilla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2015
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive SarcomaNabil Ahmed, Vita S Brawley, Meenakshi Hegde, et al.
The Journal of Experimental Medicine|March 19, 2014
BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groupsMarie-Luise Berres, Karen Phaik Har Lim, Tricia Peters, et al.
Nature Communications|November 18, 2015
Recurrent internal tandem duplications of BCOR in clear cell sarcoma of the kidneyAngshumoy Roy, Vijetha Kumar, Barry Zorman, et al.
Nature Communications|July 17, 2020
Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcomaMeenakshi Hegde, Sujith K Joseph, Farzana Pashankar, et al.
Pediatric Blood & Cancer|December 26, 2025
Factors Associated With Rare Pediatric Cancer Trial Enrollment: A Report From the Children's Oncology Group Rare Tumors CommitteeBrian R Englum, Jin Piao, Lindsay Younis, et al.
Cancer Research|November 30, 2017
TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast CancerTiara T Byrd, Kristen Fousek, Antonella Pignata, et al.
Haematologica|June 7, 2021
Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndromeAyala Tovy, Carina Rosas, Amos S Gaikwad, et al.
Pediatric Blood & Cancer|May 9, 2025
Pediatric Malignant Tumors in Malawi: A Diagnostic Report From the Kamuzu Central Hospital Pathology Laboratory 2011-2020Yolanda Gondwe, April Evans, Apatsa Matatiyo, et al.
Pageof 27